MedPath

Prospective Trial Comparing Two Different Polypropylene Meshes for Inguinal Hernias

Not Applicable
Completed
Conditions
Hernia, Inguinal
Interventions
Other: Evaluation
Device: ULTRAPRO Mesh
Device: 3DMAX
Registration Number
NCT01825187
Lead Sponsor
South East Area Health Education Center, Wilmington, NC
Brief Summary

The purpose of this research study is to measure the clinical effectiveness of two different polypropylene meshes used for laparoscopic inguinal hernias by evaluating subjects' length of hospital stay, perioperative complications, recurrence rate, pain score, comfort level and postoperative quality of life. A secondary goal of the study is to evaluate the ease of use and time it takes surgical residents to place the mesh and perform the surgery using these two different meshes.

Detailed Description

Inguinal hernia repair is one of the most common operations performed by general surgeons in the world. There are two main ways to repair an inguinal hernia, open or laparoscopic. Open compared to laparoscopic, is more invasive and leads to more scarring and longer recovery periods. Laparoscopic repair is done by making a small cut in or just below the umbilicus and has become an accepted standard for inguinal hernia repair and has become the technique of choice for recurrent inguinal hernias.

During laparoscopic repair, the placement of a prosthetic mesh aids in reinforcing the abdominal wall and allowing for tension free repair. Meshes also helps to lower the recurrence rate. The most safe and effective type of mesh prosthesis currently being used in laparoscopic inguinal hernia repairs are polypropylene meshes. There is some emerging evidence that "lighter weight" forms of polypropylene meshes may improve quality of life outcomes following surgery for inguinal hernias. Further evaluation is needed to support this evidence.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • Subjects undergoing laparoscopic repair for the treatment of either single or bilateral inguinal hernias
  • All surgical residents at New Hanover Regional Medical Center
Exclusion Criteria
  • Subjects requiring emergency surgery
  • Pregnant subjects
  • Subjects under the age of 18 years of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Evaluation of Surgical ResidentsEvaluationSurgical residents will be evaluated on the ease of use and the amount of time it takes for them to perform the surgery using these two different meshes.
Treatment Group 1ULTRAPRO MeshPatients in this group will be randomized to receive the ULTRAPRO mesh
Treatment Group 23DMAXPatients in this group will be randomized to receive the 3DMAX Mesh
Primary Outcome Measures
NameTimeMethod
Inguinal Hernia Mesh Insertion TimesDuring the procedure an average of an hour

The primary outcome measure was a comparison of mesh insertion times and were tested using a 2 × 2 ANOVA on the ranked times. Timing of the mesh placement was documented, which included time from mesh insertion in the trocar until completion of mesh fixation. Laparoscopic fixation was performed by placing four tacks; two in the pubic bone, one medial, and one lateral on the upper portion of the mesh. The types of tacks used were AbsorbaTack™ (Medtronics), sutures, CapSure™ (CR Bard) and OptiFix™ (CR Bard). Timing of mesh placement in robotic repairs included mesh placement and the time to place three suture fixation points; one at the pubis, one at the anterior, and 1 at the lateral abdominal wall at the top of the mesh.

Secondary Outcome Measures
NameTimeMethod
NASA TLX Survey Index ScoresDuring procedure an average of 1 hour

Following surgery, the Hart and Staveland's NASA Task Load Index (TLX) survey was completed by the surgeon to evaluate the surgeon's perceived difficulty and success of the operation. Scale ranges from very low (0) to very high (20) on a 20 point scale (0-20 points). For all outcome measures except performance, 0 indicates the worst outcome and 20 indicates the best outcome. For performance, 0 indicates perfect and 20 indicates failure.

Trial Locations

Locations (1)

New Hanover Regional Medical Center

🇺🇸

Wilmington, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath